Aicardi Syndrome is a rare genetic condition. It affects the brain and eyes. Key features include a missing part of the brain called the corpus callosum, which connects the two brain hemispheres. It also causes seizures starting in infancy and problems with the retina or optic nerve.
Every report comes from a Lived member, sent anonymously.
Have you tried Sabril (Vigabatrin) for Aicardi Syndrome?
Aicardi syndrome is a rare condition of brain and eye development that affects almost only girls. It is recognized by three hallmark features. The corpus callosum, the band of nerve fibers that connects the left and right halves of the brain, is missing or only partly formed. The retina, the light-sensing layer at the back of the eye, has small cream-colored defects called chorioretinal lacunae. And seizures begin in the first months of life, usually as infantile spasms: sudden jerks or stiffening of the whole body that can happen many times a day. Some people have only two of these three features, along with other typical findings. Other parts of the brain usually develop differently too. The folds on the brain's surface may not form normally, and there can be fluid-filled cysts or clusters of nerve cells in the wrong place. Together these differences explain why most people with Aicardi syndrome have frequent seizures, developmental delay and intellectual disability, and why vision is often reduced. The condition is present from birth, and symptoms typically appear at around 2 months of age. In the United States it occurs in roughly 1 in 105,000 to 167,000 newborns.
The cause of Aicardi syndrome is not known. Because it occurs almost exclusively in girls, researchers have long suspected a change in a gene on the X chromosome, but no such gene has been found despite years of searching. Recent genetic sequencing studies have found different new changes in different girls, which suggests that more than one genetic route may lead to the same pattern of brain and eye differences. Nearly every case is sporadic, meaning it arises as a new event in a family with no history of the condition. Nothing a parent did before or during pregnancy is known to cause it. Parents of an affected child are unaffected, and other relatives are not usually at increased risk; the only confirmed repeats within a family have been in identical twins. Very rarely, the condition has been diagnosed in boys who have an extra X chromosome (47,XXY, also called Klinefelter syndrome).
Aicardi syndrome is usually recognized in the first months of life, most often after an infant develops spasms or falls behind in development. There is no genetic test that confirms it, so the diagnosis rests on findings from three kinds of examination. A brain MRI (magnetic resonance imaging) scan shows whether the corpus callosum is absent or incomplete and looks for the other brain differences that often come with it. An EEG (electroencephalogram), a recording of the brain's electrical activity through small sensors on the scalp, confirms seizures and helps guide their treatment. An ophthalmologist (eye specialist) examines the back of the eye with a special instrument, because the lacunae cannot be seen any other way and are found in nearly everyone with the condition. Doctors make the diagnosis when all three classic features are present, or when two are present together with other typical features such as particular brain malformations. Experts are still refining these criteria. A few other genetic conditions can look similar, and a specialist will consider them. A missing corpus callosum on its own, without the eye findings, is a different and more common condition with a much wider range of outcomes, including children who have no symptoms.
There is no cure for Aicardi syndrome. Treatment focuses on controlling seizures and supporting development, vision, growth and comfort. Seizure control is usually the most pressing task, and often the hardest. For infantile spasms, the first-line medicines are ACTH (adrenocorticotropic hormone, a hormone injection sold as Acthar Gel), corticosteroid (steroid) medicines, and vigabatrin (Sabril), an antiseizure medicine. Vigabatrin can cause permanent loss of side vision, and its label advises against using it in people at high risk of other permanent vision loss unless the benefit clearly outweighs that risk. Because many children with Aicardi syndrome already have eye differences, that trade-off is weighed carefully, and anyone taking it needs regular vision checks. As children grow, other seizure types usually appear, and seizures often do not respond well to medicine. Many children try several medicines over time, and no single one has proven better than the others. In published reports, only about a third had seizures that were described as well controlled. A small number have had a nerve stimulation device or epilepsy surgery, with mixed results. Beyond seizures, care involves a team. Physical, occupational and speech therapy support movement, daily skills and communication, and vision services help a child make the most of the sight she has. Digestive problems such as reflux, constipation and feeding difficulty affect most children and need their own attention. The spine is watched for scoliosis (sideways curvature), which can worsen over time.
Aicardi syndrome affects people very differently, but for most it means lifelong, significant disability. Most have moderate to severe intellectual disability, though a small number have milder delays. In a large review of published cases, about a quarter of children walked on their own and fewer than one in five spoke words; many communicate without speech. Growth often slows in later childhood. Daily life usually revolves around seizure management, therapies, feeding and frequent appointments, including regular neurology and eye follow-up. Families carry a large share of the care, so therapy and educational support, caregiver help and respite matter over the long term. Life expectancy is reduced and varies widely. Prolonged seizures and complications of respiratory infections are the main dangers in childhood. In published cases, about 94% of children were alive at age 1 and 83% at age 5, and those whose symptoms began earliest, before about 2 months of age, tended to do less well. Many live well beyond childhood: one study of 408 people estimated that about 62% survive to age 27. These figures come from reported cases and family surveys, so they cannot predict any one child's outlook.
An infant who has repeated sudden jerks or stiffening of the body, or who is falling behind in development, should be evaluated by a doctor. Children with the diagnosis need regular follow-up with neurology, eye care and the other specialists involved in their care. Contact the care team promptly if spasms are new or suspected, since experts advise an EEG within a few days and treatment right away if spasms are confirmed. Call promptly, too, when seizures become more frequent, or when a cold or chest infection makes breathing harder or feeding difficult. Call 911 if a seizure lasts more than 2 to 5 minutes, if another seizure starts soon after one ends, if a child does not wake up or return to usual behavior afterward, or if a seizure is clearly different from the child's usual ones.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Aicardi Syndrome is like, what's helped you, or ask the community a question.